Literature DB >> 7182459

In vitro and in vivo evaluation of the tissue-to-blood partition coefficient for physiological pharmacokinetic models.

J H Lin, Y Sugiyama, S Awazu, M Hanano.   

Abstract

An important parameter used in physiologically based pharmacokinetic models is the partition coefficient (Kp), which is defined as the ratio of tissue drug concentration to the concentration of drug in the emergent venous blood of the tissue. Since Kp is governed by reversible binding to protein and other constituents in blood and tissue, an attempt was made here to estimate the Kp values for a model drug ethoxybenzamide (EB) by means of in vitro binding studies and to compare these Kp values to those obtained from in vivo kinetic parameters observed following the administration of EB by two different routes, i.e., i.v. bolus injection and constant rate infusion. The Kp values obtained by using these three different methods were in reasonably good agreement suggesting that binding data obtained in vitro can successfully be used to estimate in vivo distribution.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7182459     DOI: 10.1007/bf01062545

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  16 in total

1.  Physiologically based pharmacokinetic model for digoxin distribution and elimination in the rat.

Authors:  L I Harrison; M Gibaldi
Journal:  J Pharm Sci       Date:  1977-08       Impact factor: 3.534

2.  Estimation of tissue-to-plasma partition coefficients used in physiological pharmacokinetic models.

Authors:  H S Chen; J F Gross
Journal:  J Pharmacokinet Biopharm       Date:  1979-02

3.  Critical evaluation of use of effective protein fractions in developing pharmacokinetic models for drug distribution.

Authors:  D Shen; M Gibaldi
Journal:  J Pharm Sci       Date:  1974-11       Impact factor: 3.534

4.  Methotrexate pharmacokinetics.

Authors:  K B Bischoff; R L Dedrick; D S Zaharko; J A Longstreth
Journal:  J Pharm Sci       Date:  1971-08       Impact factor: 3.534

5.  Thiopental pharmacokinetics.

Authors:  K B Bischoff; R L Dedrick
Journal:  J Pharm Sci       Date:  1968-08       Impact factor: 3.534

6.  Preliminary model for methotrexate pharmacokinetics.

Authors:  K B Bischoff; R L Dedrick; D S Zaharko
Journal:  J Pharm Sci       Date:  1970-02       Impact factor: 3.534

7.  Interspecies difference in drug protein binding-temperature and protein concentration dependency: effect on calculation of effective protein fraction.

Authors:  Y Igari; Y Sugiyama; S Awazu; M Hanano
Journal:  J Pharm Sci       Date:  1981-09       Impact factor: 3.534

8.  Lidocaine disposition kinetics in monkey and man. I. Prediction by a perfusion model.

Authors:  N Benowitz; F P Forsyth; K L Melmon; M Rowland
Journal:  Clin Pharmacol Ther       Date:  1974-07       Impact factor: 6.875

9.  Hepatic clearance of drugs. I. Theoretical considerations of a "well-stirred" model and a "parallel tube" model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance.

Authors:  K S Pang; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1977-12

10.  Correlation between in vitro and in vivo drug metabolism rate: oxidation of ethoxybenzamide in rat.

Authors:  J H Lin; M Hayashi; S Awazu; M Hanano
Journal:  J Pharmacokinet Biopharm       Date:  1978-08
View more
  25 in total

1.  Kinetic analysis of the dose-dependent hepatic handling of 1-anilino-8-naphthalene sulfonate in rats.

Authors:  Y B Chung; S Miyauchi; Y Sugiyama; H Harashima; T Iga; M Hanano
Journal:  J Pharmacokinet Biopharm       Date:  1990-08

2.  Prediction of in vivo tissue distribution from in vitro data. 3. Correlation between in vitro and in vivo tissue distribution of a homologous series of nine 5-n-alkyl-5-ethyl barbituric acids.

Authors:  Peter Ballard; David E Leahy; Malcolm Rowland
Journal:  Pharm Res       Date:  2003-06       Impact factor: 4.200

Review 3.  Whole body pharmacokinetic models.

Authors:  Ivan Nestorov
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

4.  Significance of binding to Na,K-ATPase in the tissue distribution of ouabain in guinea pigs.

Authors:  H Harashima; M Mamiya; M Yamazaki; Y Sugiyama; Y Sawada; T Iga; M Hanano
Journal:  Pharm Res       Date:  1992-04       Impact factor: 4.200

Review 5.  Methods of determining plasma and tissue binding of drugs. Pharmacokinetic consequences.

Authors:  G M Pacifici; A Viani
Journal:  Clin Pharmacokinet       Date:  1992-12       Impact factor: 6.447

6.  An understanding of flow- and diffusion-limited vs. carrier-mediated hepatic transport: a simulation study.

Authors:  W P Geng; K Poon; K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1995-08

7.  Area method for the estimation of partition coefficients for physiological pharmacokinetic models.

Authors:  J M Gallo; F C Lam; D G Perrier
Journal:  J Pharmacokinet Biopharm       Date:  1987-06

8.  Seeking Nonspecific Binding: Assessing the Reliability of Tissue Dilutions for Calculating Fraction Unbound.

Authors:  William J Jusko; Emilie A G Molins; Vivaswath S Ayyar
Journal:  Drug Metab Dispos       Date:  2020-08-05       Impact factor: 3.922

9.  Prediction of drug distribution in rat and humans using an artificial neural networks ensemble and a PBPK model.

Authors:  Paulo Paixão; Natália Aniceto; Luís F Gouveia; José A G Morais
Journal:  Pharm Res       Date:  2014-05-28       Impact factor: 4.200

10.  Theoretical consideration of drug distribution kinetics in a noneliminating organ: comparison between a "homogeneous (well-stirred)" model and "nonhomogeneous (tube)" model.

Authors:  T Terasaki; Y Sugiyama; T Iga; Y Sawada; M Hanano
Journal:  J Pharmacokinet Biopharm       Date:  1985-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.